Substituted Carbamate Derivatives as Modulators of Corticotropin-Releasing Factor Receptor Activity

摘要

The disclosure provides compounds of formula (I), including their salts, as well as compositions and methods of using the compounds. The compounds are CRF receptor antagonists and may be useful for treating disorders associated with abnormal CRF levels or aberrant functioning of CRF receptors.